Ignite Creation Date:
2025-12-25 @ 2:28 AM
Ignite Modification Date:
2025-12-26 @ 1:02 AM
Study NCT ID:
NCT07272434
Status:
RECRUITING
Last Update Posted:
2025-12-09
First Post:
2025-11-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell)
Sponsor:
MAXVAX Biotechnology Limited Liability Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-10-22
Start Date Type:
ACTUAL
Primary Completion Date:
2026-07-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2025-11-14
First Submit QC Date:
None
Study First Post Date:
2025-12-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-26
Last Update Post Date:
2025-12-09
Last Update Post Date Type:
ESTIMATED